Delivery Order SPE2DB20D2001-SPE2DB21FM56H
- Not listed
- This federal contract award, valued at $1,638.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Montelukast Sodium 10 mg Tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award, with the ID SPE2DB20D1004|SPE2DB24FF8A5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 1,000 units of Montelukast Sodium 10mg tablets, a pharmaceutical product, with a ceiling value of $1,054.65. The contract is structured as a firm fixed price delivery order and does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,022.88, is for the delivery of 1,000 units of the prescription drug Montelukast Sodium 10 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at up to $999,999,999.00 and runs through December 31, 2025. This IDC...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,054.96 firm fixed-price contract is for the delivery of Montelukast Sodium 4 mg granules, a medication used to treat asthma and allergies. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Montelukast Sodium 5 mg Chewable Tablets in 50-count units. The $1,744.90 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 5, 2023. The contract is not designated as a set-aside award. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award, SPE2DB22D1002|SPE2DB24FKYA6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg Chewable Tablets, a medication used to treat asthma and allergy symptoms. The contract is a firm fixed-price delivery order with a total ceiling value of $2,868.26 and an ultimate completion date of February 14, 2024....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg chewable tablets, a medication used to treat asthma and allergies. The contract has a firm fixed price, a ceiling value of $1,495.97, and an ultimate completion date of July 16, 2025. The contract is not set aside for any specific business type....
- This federal contract award is for the delivery of Montelukast sodium 5 mg chewable tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,169.08 and a completion date of August 15, 2024. The prime contractor is Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, which holds several indefinite delivery contracts (IDCs) with various federal agencies, including the DLA Troop Support Medical and the Department of Justice...
- The Defense Logistics Agency awarded a delivery order valued at $1,761.91 to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 4 mg Granules (30-count packaging) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside contract will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate office. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $2,861.29 to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 5 mg chewable tablets (30-count) on December 19, 2025, with completion expected by December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB21FM56HDelivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the drug Montelukast Sodium 10 mg Tablets. The contract has a firm fixed price of $7,720.29 and a period of performance ending on August 4, 2021. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov) and holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000.00, respectively. These IDCs enable the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 8/3/21 |